|  |  |  | Antibody concentration (μg/ml) mean ± SD | |||
---|---|---|---|---|---|---|---|
 |  |  |  | Vaccine | |||
Isotype | Day | Treatment | Â | BoNT/A(H c) | rF1-V | rPA | STEBVax |
IgM | 70 | Control | (n = 8) | 3.07+/-0.87 | 2.99+/-1.47 | 6.31+/-3.16 | 4.76+/-3.62 |
 | 70 | Vaccinated | (n = 24) | 5.47+/-2.20 | 11.2+/-4.04 | 13.7+/-9.28 | 9.07+/-2.74 |
 |  | p-value* |  | 0.0001 | < 0.0001 | 0.002 | 0.012 |
IgG | 14 | Control | (n = 8) | 0.31+/-0.15 | 2.1+/-3.1 | 0.31+/-0.12 | 1.25+/-1.76 |
 | 14 | Vaccinated | (n = 24) | 1.4+/-1.1 | 421+/-196 | 86+/-46 | 121+/-109 |
 |  | p-value |  | < 0.0001 | < 0.0001 | < 0.0001 | < 0.0001 |
 | 42 | Control | (n = 8) | 0.28+/-0.22 | 1.95+/-0.98 | 2.2+/-1.4 | 1.23+/-0.91 |
 | 42 | Vaccinated | (n = 24) | 4+/-2.1 | 767+/-382 | 689+/-397 | 323+/-187 |
 |  | p-value |  | < 0.0001 | < 0.0001 | < 0.0001 | < 0.0001 |
 | 70 | Control | (n = 8) | 0.65+/-0.37 | 1.05+/-1.08 | 0.91+/-0.44 | 1.93+/-1.25 |
 | 70 | Vaccinated | (n = 24) | 48+/-13 | 2331+/-303 | 2245+/-1224 | 1340+/-215 |
 |  | p-value |  | < 0.0001 | < 0.0001 | < 0.0001 | < 0.0001 |